Extension Vafseo

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

PatentsGlobal

Akebia Therapeutics Secures New Patent and Five-Year Extension for Vafseo® (vadadustat), Bolstering Market Exclusivity Through 2036

Akebia Therapeutics has been granted a new patent and qualified for a five-year patent term extension on its composition of matter patent for Vafseo® (vadadustat). This development strengthens the company’s intellectual property portfolio and extends market exclusivity for Vafseo®—an oral treatment for anemia due to c…

Wednesday, June 10, 2026

Newsletters & Digests

Follow Extension Vafseo

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Explore

All newsroom coverage Filtered archive